Skip to content

Clinical trials

Completed Phase 2 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 2 Status: Completed Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20026
20033
20047
20057
20066
20076
20087
20097
20107
20117
20128
20133
20143
20159
20167
20177
20184
20193
20202
20219
20226
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed136

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Massachusetts General Hospital4
National Institute on Alcohol Abuse and Alcoholism (NIAAA)4
IWK Health Centre3
National Institute of Mental Health (NIMH)3
AstraZeneca2
Dennis Charney2
Duke University2
Indiana University2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders136
Generalized Anxiety Disorder10
Pain9
Phobia, Social9
Major Depressive Disorder8
Alcoholism7
Breast Neoplasms6
Sleep Initiation and Maintenance Disorders6
Stress Disorders, Post-Traumatic5
Autism Spectrum Disorder4

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.